How Insulin Resistance Changes Your Hormones, Inflammation, and Breast Cancer Risk
- By Dr. Ryan Wagner PharmD
- October 8, 2026
- 9 Min Read
You know insulin resistance matters for weight. Your doctor has probably mentioned it in the context of diabetes risk or told you to lose weight to improve your insulin sensitivity. You’ve heard it affects metabolism, energy, and how your body stores fat.
What nobody’s telling you is that insulin resistance fundamentally changes your cellular environment in ways that affect cancer risk, particularly breast cancer.
Here’s the mechanism that’s rarely explained: insulin isn’t just a blood sugar regulating hormone. It’s a growth signal. When insulin is chronically elevated (which happens with insulin resistance), it tells cells to grow, proliferate, and resist normal cell death signals. It activates pathways that promote inflammation and angiogenesis (new blood vessel formation that feeds growing tissues). It increases production of growth factors like IGF-1 (insulin-like growth factor 1), which directly stimulates cell division (1).
In a metabolically healthy woman, insulin spikes briefly after meals, does its job of shuttling glucose into cells, then returns to baseline. But in insulin resistance, insulin stays elevated for hours after eating and baseline levels creep higher over time. Your cells are bathed in growth signals continuously.
At the same time, insulin resistance increases inflammation throughout the body. Inflammatory cytokines create an environment where cells are more likely to develop DNA damage, less likely to repair that damage properly, and more likely to survive when they should be eliminated through normal cell death processes.
And critically for breast cancer specifically, insulin resistance increases estrogen production. Fat tissue (especially visceral fat that accumulates with insulin resistance) produces estrogen through an enzyme called aromatase. More insulin resistance means more visceral fat means more estrogen production. Excess estrogen, particularly when it’s not being metabolized properly by an overwhelmed liver, creates additional growth signals for breast tissue (2).
I’m not sharing this to create fear. I’m sharing this because insulin resistance is measurable, identifiable, and reversible. Understanding this connection gives you agency to change your cellular environment before problems develop.
How Insulin Resistance Raises Breast Cancer Risk
Insulin resistance doesn’t affect breast tissue through just one mechanism. It changes three things at once, and each one makes the others worse.
Growth
Signaling
Chronically high insulin raises IGF-1, keeping breast cells under constant instructions to grow, divide, and resist normal cell death.
Chronic Inflammation
Low-grade inflammation damages DNA and switches on survival signals, so damaged cells stick around when they should be cleared.
The Estrogen Shift
Visceral fat makes more estrogen, the liver shifts toward inflammatory metabolites, and lower SHBG leaves more free estrogen active.
The Insulin-IGF-1 Pathway That Promotes Cell Growth
Insulin and IGF-1 are closely related hormones that share signaling pathways. When insulin is chronically elevated, IGF-1 production increases. IGF-1 binds to receptors on cell surfaces and activates pathways (particularly PI3K/AKT and MAPK) that tell cells to grow, divide, and resist death signals.
In normal physiology, this is appropriate. You need cells to grow and divide for wound healing, tissue repair, and normal turnover. But when these growth signals are constantly active (from chronically elevated insulin and IGF-1), cells receive continuous instructions to proliferate.
Breast tissue is particularly sensitive to IGF-1 signaling. Breast cells have abundant IGF-1 receptors, and when these receptors are constantly activated by elevated IGF-1, the tissue receives persistent growth stimulation. Studies consistently show that women with higher circulating IGF-1 levels have increased breast cancer risk, and that insulin resistance (which drives IGF-1 production) correlates with this elevation (3).
Concerned about insulin resistance but not sure if you have it? Take the quiz: What’s Your Hormone Type? Which of the 4 Imbalance Patterns Are You? Get your assessment here.
"You get the worst of both worlds: impaired metabolic function and enhanced growth signaling."
— Dr. Ryan Wagner, Pharm.D
The stubborn weight gain and inability to lose fat despite calorie restriction that characterizes insulin resistance is the same metabolic dysfunction creating this problematic cellular environment. The body that’s resistant to insulin’s metabolic signals (glucose uptake into muscle and liver) is still responsive to insulin’s growth-promoting signals. You get the worst of both worlds: impaired metabolic function and enhanced growth signaling.
The visceral fat that accumulates around your midsection with insulin resistance isn’t just cosmetically problematic. It’s metabolically active tissue that produces inflammatory cytokines and estrogen, both of which further increase breast cancer risk. The more visceral fat you have, the higher your inflammatory markers, and the more estrogen you’re producing independent of ovarian function.
The Inflammatory Environment That Damages DNA
Chronic Inflammation
Insulin resistance keeps IL-6, TNF-α, and IL-1β elevated.
Oxidative Stress
Inflammatory cytokines create oxidative stress inside cells.
DNA Damage
DNA gets damaged, and the normal repair process is impaired.
Damaged Cells Survive
NF-κB keeps damaged cells alive and dividing instead of clearing them.
Insulin resistance creates chronic low-grade inflammation throughout the body. This inflammation isn’t dramatic like an infection or injury. It’s subtle, systemic, and persistent. But this chronic inflammatory state has profound effects on cellular health.
Inflammatory cytokines (IL-6, TNF-alpha, IL-1β) create oxidative stress, which damages cellular structures including DNA. When DNA is damaged, cells are supposed to either repair the damage or undergo apoptosis (programmed cell death) to prevent the damaged DNA from being replicated. But the same inflammatory environment that’s causing DNA damage also impairs these protective mechanisms.
Inflammation activates transcription factors like NF-κB that promote cell survival and proliferation even when DNA damage is present. Cells that should be eliminated persist and continue dividing despite carrying genetic errors. Over time, this increases the likelihood that cells will accumulate enough mutations to become cancerous (4).
The 3pm energy crash that’s so common with insulin resistance isn’t just about blood sugar fluctuations. It reflects the inflammatory and metabolic dysfunction occurring at the cellular level. When inflammation is high and mitochondrial function is impaired (which happens with insulin resistance), energy production is inefficient. You feel exhausted because your cells literally can’t produce energy efficiently.
That same mitochondrial dysfunction that’s making you tired is also affecting how cells respond to growth signals and how they repair DNA damage. Healthy mitochondria aren’t just energy producers; they’re involved in regulating cell death pathways. Dysfunctional mitochondria allow damaged cells to survive when they shouldn’t.
The Estrogen Connection Nobody Mentions
More Estrogen Production
Visceral fat converts androgens into estrogen through aromatase. More visceral fat means more estrogen, especially after menopause.
Shifted Estrogen Metabolism
An overwhelmed, often fatty liver pushes estrogen toward inflammatory metabolites like 16α-hydroxyestrone and 4-hydroxyestrone.
More Free
Estrogen
Insulin resistance lowers SHBG, so more estrogen circulates unbound and active, even when total levels look normal.
Breast cancer is often described as hormone-driven, meaning estrogen and progesterone affect cancer cell growth. But what’s rarely explained is that insulin resistance fundamentally changes your estrogen environment in multiple ways.
First, insulin resistance increases aromatase activity in fat tissue. Aromatase converts androgens into estrogen. The more visceral fat you have, the more aromatase activity, the more estrogen production. Postmenopausal women are particularly affected because once ovarian estrogen production declines, fat tissue becomes the primary source of estrogen. Insulin-resistant postmenopausal women can have significantly elevated estrogen levels from fat tissue production alone.
Second, insulin resistance affects how estrogen is metabolized. The liver metabolizes estrogen through various pathways, producing different metabolites. Some are protective (2-hydroxyestrone), others are inflammatory and potentially carcinogenic (16-alpha-hydroxyestrone, 4-hydroxyestrone). Insulin resistance, which often coexists with fatty liver and impaired liver detoxification, shifts estrogen metabolism toward the problematic pathways (5).
Third, insulin resistance lowers sex hormone binding globulin (SHBG), which is the protein that binds to estrogen and testosterone in the bloodstream. When SHBG is low, more estrogen circulates in free (unbound) form. Free estrogen is the biologically active form that can bind to receptors and exert effects on tissues. So even if total estrogen isn’t dramatically elevated, the amount of free estrogen available to stimulate breast tissue is higher.
Not sure if your symptoms indicate insulin resistance or another hormone pattern? Take the quiz: What’s Your Hormone Type? Identify your specific imbalance pattern here.
The combination of increased estrogen production, shifted metabolism toward inflammatory metabolites, and higher free estrogen creates an environment where breast tissue receives excessive growth stimulation. Add the insulin and IGF-1 signaling on top of that, and you have multiple converging pathways all promoting cellular proliferation.
THE HIDDEN STAGE
Why "Normal" Blood Sugar Doesn't Mean You're Safe
Most women who have insulin resistance don’t know it because their fasting blood sugar is normal. Standard medical testing checks fasting glucose and maybe HbA1c. If these are in the normal range (fasting glucose under 100 mg/dL, HbA1c under 5.7%), you’re told your blood sugar is fine and insulin resistance is ruled out.
But insulin resistance develops years before blood sugar becomes abnormal. In the early stages, your pancreas compensates by producing more and more insulin to keep blood sugar in the normal range. Your fasting glucose might be 85, which looks great. But your fasting insulin might be 15 or 20 (when optimal is under 5), indicating that your pancreas is working overtime to maintain that normal glucose.
WHAT STANDARD LABS SHOW
WHAT'S ACTUALLY HAPPENING
01 / Fasting Glucose: 85
Well under the 100 mg/dL cutoff, so you’re told your blood sugar is fine.
01 / Fasting Insulin: 15–20
Your pancreas is working overtime to keep glucose normal. Optimal is under 5.
02 / HbA1c Under 5.7%
Three-month average blood sugar looks normal, so insulin resistance is “ruled out.”
02 / Years Ahead of the Labs
Insulin resistance develops years before glucose or HbA1c ever become abnormal
03 /"You're Fine"
No further testing is ordered.
03 / Already Active
Insulin, IGF-1, inflammation, and visceral fat are climbing, and your estrogen environment is shifting.
This is the stage where the cancer-promoting effects of insulin resistance are already active. Your insulin is elevated. Your IGF-1 is elevated. Your inflammatory markers are climbing. Your visceral fat is accumulating. Your estrogen environment is shifting. But because your glucose is “normal,” the problem goes undetected.
The cravings, particularly for sweets or carbs in the afternoon, are a direct signal of insulin resistance. Your cells aren’t taking up glucose efficiently despite high insulin, so your brain perceives inadequate fuel availability and triggers hunger and cravings, especially for quick-energy foods. You’re not lacking willpower. Your metabolic signaling is dysfunctional.
The poor sleep that often accompanies insulin resistance compounds the problem. Sleep disruption increases insulin resistance, increases inflammation, increases cortisol (which further worsens insulin resistance), and impairs the cellular repair processes that happen during deep sleep. You’re creating a vicious cycle where insulin resistance impairs sleep, and poor sleep worsens insulin resistance.
The Postmenopausal Risk That Accelerates
Breast cancer risk increases significantly after menopause, and insulin resistance is a major reason why. Before menopause, the ovaries produce most of your estrogen in a cyclic, regulated pattern. After menopause, estrogen production shifts primarily to fat tissue through aromatase activity.
WHAT CHANGES
BEFORE MENOPAUSE
AFTER MENOPAUSE
Main Estrogen Source
The ovaries, in a regulated pattern.
Fat tissue, through aromatase.
Pattern
Cyclical rise and fall each month.
Continuous and unregulated.
What Drives the Amount
The brain–ovary signaling cycle.
How much visceral fat you carry.
Women who are insulin resistant going into menopause suddenly have unregulated estrogen production that’s directly proportional to their visceral fat mass and aromatase activity. There’s no longer the cyclical rise and fall of estrogen that characterized their reproductive years. Instead, there’s continuous estrogen production from fat tissue, and the amount depends on how much visceral fat they have.
Additionally, postmenopausal women are more likely to gain weight and become more insulin resistant due to declining metabolic rate, changing activity levels, and hormonal shifts that affect how the body stores fat. The combination of worsening insulin resistance and shifting to fat-tissue-derived estrogen production creates a particularly problematic metabolic environment for breast tissue.
Studies consistently show that insulin resistance and metabolic syndrome are more strongly associated with breast cancer risk in postmenopausal women than in premenopausal women. The risk isn’t absolute, but the correlation is clear and significant enough that addressing insulin resistance should be considered a protective strategy (6).
The stubborn weight gain that so many women experience in perimenopause and after menopause isn’t just about calories or hormones in isolation. It’s about insulin resistance worsening as estrogen and progesterone decline, creating a metabolic state where fat accumulation (particularly visceral fat) is favored, and that fat accumulation then produces more estrogen and inflammation in an unregulated way.
What Actually Needs to Be Assessed
HOMA-IR
Insulin resistance, even when glucose is normal
Fasting Insulin
How hard your pancreas is working
HbA1c
Average blood sugar over 3 months
Triglycerides & HDL
The lipid pattern insulin resistance creates
hs-CRP
Your overall inflammatory burden
SHBG + Hormone Panel
How much estrogen is free and active
Body Composition
Visceral fat, not just weight or BMI
Liver Function Markers
Fatty liver affecting estrogen metabolism
Continuous Glucose Monitor
After-meal patterns that fasting labs miss
Want to assess your personal insulin resistance and metabolic risk? Take the quiz: What’s Your Hormone Type? Get your hormone and metabolic pattern assessment here.
Symptoms I Listen For
But beyond labs, I’m listening to symptoms. These point to insulin resistance even before labs are dramatically abnormal:
- Stubborn weight gain, especially around the midsection
- Intense cravings for carbs or sweets
- Energy crashes in the afternoon
- Difficulty losing weight despite calorie restriction
- Poor sleep
- Feeling exhausted
How We Actually Reverse Insulin Resistance
The critical point: insulin resistance is reversible. The metabolic and inflammatory environment it creates can be changed. You’re not stuck with elevated cancer risk because of your current metabolic state.
Blood Sugar–Stabilizing Nutrition
Prioritize protein, healthy fats, and fiber while cutting refined carbs and sugar. Carbs are timed earlier in the day, when insulin sensitivity is higher.
Strength & Interval Training
Muscle is the main site of glucose disposal. Resistance training and HIIT make muscle more insulin sensitive, so your body needs less insulin.
Sleep Optimization
Short sleep significantly worsens insulin resistance. Aim for 7–8 hours, keep consistent sleep and wake times, and screen for sleep apnea.
Stress Management
Chronic stress raises cortisol, which directly promotes insulin resistance. Nervous system regulation and real rest are essential.
Targeted Supplements
Berberine, myo-inositol, alpha-lipoic acid, chromium, and magnesium can improve insulin sensitivity when combined with lifestyle changes.
Reducing Visceral Fat
As visceral fat drops, inflammation and aromatase activity drop with it, improving the whole metabolic environment.
Gut Repair
Gut inflammation and endotoxin (LPS) from intestinal permeability drive systemic inflammation that worsens insulin resistance.
Liver & Estrogen Support
Supporting liver function improves how estrogen is metabolized and cleared, reducing the burden of inflammatory metabolites.
The goal isn’t just weight loss (though that often happens as insulin sensitivity improves). The goal is changing the cellular environment from one that promotes growth, inflammation, and cellular dysfunction to one that supports normal cell regulation, DNA repair, and appropriate cell death when damage occurs.
What Happens When Insulin Sensitivity Is Restored
When insulin sensitivity improves, the changes are both felt and measurable.
- Energy stabilizes. The 3pm crash disappears as blood sugar regulation and mitochondrial function improve.
- Cravings fade. When cells take up glucose efficiently, the constant carb cravings stop.
- Weight loss becomes possible, especially from the midsection.
- Sleep improves as the metabolic dysfunction disrupting it resolves.
- Inflammatory markers drop. CRP and cytokine levels decrease on lab testing.
- Your hormone environment improves. Less estrogen from fat tissue, higher SHBG, and more efficient estrogen metabolism.
- Insulin and IGF-1 normalize, removing the constant growth signaling.
But more than any single marker, the cellular environment shifts from one that favors proliferation and dysfunction to one that supports normal cellular regulation and health. You’re changing your terrain at the most fundamental level.
Your Next Step
If you’re recognizing yourself in these patterns (stubborn midsection weight, afternoon crashes, intense cravings, poor sleep), the next step is understanding your insulin resistance status, not just your weight.
Find Your Pattern
Start by finding out which hormone pattern your symptoms fit, including whether insulin resistance is part of your picture
Talk It Through
If you would rather talk through your specific picture, I also offer a free discovery call. No pressure, just a conversation about whether functional medicine is the right next step for you.
Insulin resistance isn’t just about weight or diabetes risk. It’s about the cellular environment you’re creating every day. Let’s optimize yours.
Frequently Asked Questions
Does insulin resistance increase breast cancer risk?
Insulin resistance is linked to higher breast cancer risk, particularly after menopause. Chronically high insulin raises IGF-1 growth signaling, drives inflammation, and shifts the estrogen environment toward more production and more free estrogen. It raises risk, but it doesn’t mean you will develop cancer.
Can I have insulin resistance with normal blood sugar?
Yes. In the early stages, your pancreas produces extra insulin to keep glucose in range, so fasting glucose and HbA1c can look normal for years. Fasting insulin and HOMA-IR reveal insulin resistance much earlier.
What is a good fasting insulin level?
In my practice, I like to see fasting insulin under 5 µIU/mL. Standard reference ranges are much wider, so a “normal” result can still mean your pancreas is working overtime. It’s best interpreted alongside glucose, as HOMA-IR, and your symptoms.
Scientific References & Clinical Studies
- Gallagher EJ, LeRoith D. Obesity and diabetes: the increased risk of cancer and cancer-related mortality. Physiol Rev. 2015;95(3):727-748. doi:10.1152/physrev.00030.2014
- Arcidiacono B, Iiritano S, Nocera A, et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012;2012:789174. doi:10.1155/2012/789174
- Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer. 2015;14:43. doi:10.1186/s12943-015-0291-7
- Orgel E, Mittelman SD. The links between insulin resistance, diabetes, and cancer. Curr Diab Rep. 2013;13(2):213-222. doi:10.1007/s11892-012-0356-6
- Ferguson LR, Chen H, Collins AR, et al. Genomic instability in human cancer: molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Semin Cancer Biol. 2015;35 Suppl:S5-S24. doi:10.1016/j.semcancer.2015.03.005
- Esposito K, Chiodini P, Capuano A, et al. Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis. Menopause. 2013;20(12):1301-1309. doi:10.1097/GME.0b013e31828ce95d
